Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells - PubMed (original) (raw)
. 2006 Mar 24;341(4):1135-40.
doi: 10.1016/j.bbrc.2006.01.072. Epub 2006 Jan 26.
Affiliations
- PMID: 16460677
- DOI: 10.1016/j.bbrc.2006.01.072
Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells
Katharina Timper et al. Biochem Biophys Res Commun. 2006.
Abstract
Mesenchymal stem cells (MSC) from mouse bone marrow were shown to adopt a pancreatic endocrine phenotype in vitro and to reverse diabetes in an animal model. MSC from human bone marrow and adipose tissue represent very similar cell populations with comparable phenotypes. Adipose tissue is abundant and easily accessible and could thus also harbor cells with the potential to differentiate in insulin producing cells. We isolated human adipose tissue-derived MSC from four healthy donors. During the proliferation period, the cells expressed the stem cell markers nestin, ABCG2, SCF, Thy-1 as well as the pancreatic endocrine transcription factor Isl-1. The cells were induced to differentiate into a pancreatic endocrine phenotype by defined culture conditions within 3 days. Using quantitative PCR a down-regulation of ABCG2 and up-regulation of pancreatic developmental transcription factors Isl-1, Ipf-1, and Ngn3 were observed together with induction of the islet hormones insulin, glucagon, and somatostatin.
Similar articles
- Multipotential nestin and Isl-1 positive mesenchymal stem cells isolated from human pancreatic islets.
Eberhardt M, Salmon P, von Mach MA, Hengstler JG, Brulport M, Linscheid P, Seboek D, Oberholzer J, Barbero A, Martin I, Müller B, Trono D, Zulewski H. Eberhardt M, et al. Biochem Biophys Res Commun. 2006 Jul 7;345(3):1167-76. doi: 10.1016/j.bbrc.2006.05.016. Epub 2006 May 11. Biochem Biophys Res Commun. 2006. PMID: 16713999 - New simple and rapid method for purification of mesenchymal stem cells from the human umbilical cord Wharton jelly.
Montanucci P, Basta G, Pescara T, Pennoni I, Di Giovanni F, Calafiore R. Montanucci P, et al. Tissue Eng Part A. 2011 Nov;17(21-22):2651-61. doi: 10.1089/ten.TEA.2010.0587. Epub 2011 Sep 6. Tissue Eng Part A. 2011. PMID: 21679124 - Redox-mediated enrichment of self-renewing adult human pancreatic cells that possess endocrine differentiation potential.
Linning KD, Tai MH, Madhukar BV, Chang CC, Reed DN Jr, Ferber S, Trosko JE, Olson LK. Linning KD, et al. Pancreas. 2004 Oct;29(3):e64-76. doi: 10.1097/00006676-200410000-00015. Pancreas. 2004. PMID: 15367896 - Making surrogate β-cells from mesenchymal stromal cells: perspectives and future endeavors.
Bhonde RR, Sheshadri P, Sharma S, Kumar A. Bhonde RR, et al. Int J Biochem Cell Biol. 2014 Jan;46:90-102. doi: 10.1016/j.biocel.2013.11.006. Epub 2013 Nov 22. Int J Biochem Cell Biol. 2014. PMID: 24275096 Review. - Stem cells with potential to generate insulin producing cells in man.
Zulewski H. Zulewski H. Swiss Med Wkly. 2006 Oct 14;136(41-42):647-54. doi: 10.4414/smw.2006.11425. Swiss Med Wkly. 2006. PMID: 17103343 Review.
Cited by
- Human mesenchymal stem/stromal cell based-therapy in diabetes mellitus: experimental and clinical perspectives.
Zeinhom A, Fadallah SA, Mahmoud M. Zeinhom A, et al. Stem Cell Res Ther. 2024 Oct 29;15(1):384. doi: 10.1186/s13287-024-03974-z. Stem Cell Res Ther. 2024. PMID: 39468609 Free PMC article. Review. - Acquisition of durable insulin-producing cells from human adipose tissue-derived mesenchymal stem cells as a foundation for cell- based therapy of diabetes mellitus.
Nour Eldeen G, Aglan HA, Mahmoud NS, Abdel Rasheed M, Azmy OM, Ahmed HH. Nour Eldeen G, et al. Sci Rep. 2024 Oct 18;14(1):24417. doi: 10.1038/s41598-024-74527-w. Sci Rep. 2024. PMID: 39424616 Free PMC article. - DNA Methyltransferase Inhibition by RG108 Improves Stemness and Multipotential Differentiation of Human Adipose Tissue-derived Stem Cells.
Asgharian R, Hashemi A, Javeri A, Fakhr Taha M. Asgharian R, et al. Iran J Biotechnol. 2024 Apr 1;22(2):e3863. doi: 10.30498/ijb.2024.435096.3863. eCollection 2024 Apr. Iran J Biotechnol. 2024. PMID: 39220336 Free PMC article. - Current status of stem cell therapy for type 1 diabetes: a critique and a prospective consideration.
Ghoneim MA, Gabr MM, El-Halawani SM, Refaie AF. Ghoneim MA, et al. Stem Cell Res Ther. 2024 Jan 29;15(1):23. doi: 10.1186/s13287-024-03636-0. Stem Cell Res Ther. 2024. PMID: 38281991 Free PMC article. Review. - Progress and application of adipose-derived stem cells in the treatment of diabetes and its complications.
Yan D, Song Y, Zhang B, Cao G, Zhou H, Li H, Sun H, Deng M, Qiu Y, Yi W, Sun Y. Yan D, et al. Stem Cell Res Ther. 2024 Jan 2;15(1):3. doi: 10.1186/s13287-023-03620-0. Stem Cell Res Ther. 2024. PMID: 38167106 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous